Mead Johnson Nutrition Company (MJN) : The highest level Mead Johnson Nutrition Company (MJN) is projected to reach is $96 for the short term and the lowest estimate is at $75. The consolidated price target from 6 rating analysts who initiate coverage on the stock is $87.67 and the possibility the share price can swing is $6.98.
Mead Johnson Nutrition Company (MJN) has an average broker rating of 2.36, which is interpreted as a Buy, as rated by 11 equity analysts. Nonetheless, 3 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. 1 other analysts advise a Buy. Nevertheless, the majority of 7 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 3, which is also a Hold.
Also, UBS initiates coverage on Mead Johnson Nutrition Company (NYSE:MJN) The current rating of the shares is Neutral. The rating by the firm was issued on August 24, 2016.
Mead Johnson Nutrition Company (NYSE:MJN): The stock opened at $84.60 on Thursday but the bulls could not build on the opening and the stock topped out at $84.71 for the day. The stock traded down to $82.73 during the day, due to lack of any buying support eventually closed down at $83.32 with a loss of -2.06% for the day. The stock had closed at $85.07 on the previous day. The total traded volume was 1,773,221 shares.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, childrens nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas, childrens milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company operates through three segments: Asia, Latin America and North America/Europe. The Companys Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe.